Evidence map›Paper›PMID 35699243›Full record

ArticleJournal of clinical pharmacy and therapeutics2022

Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions.

Nour Isleem, Sadim Shoshaa, Ahmad AbuGhalyoun, Mohamad Khatib, Lina Mohammad Naseralallah, Mohammed Ibn-Mas'ud Danjuma, Mohamed Saad

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical pharmacy and therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Nour IsleemClinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0001-6408-2971
Sadim ShoshaaPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Ahmad AbuGhalyounPharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Mohamad KhatibCritical Care and Pulmonary Medicine, Hamad Medical Corporation, Doha, Qatar.
Lina Mohammad NaseralallahClinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0003-3035-1357
Mohammed Ibn-Mas'ud DanjumaDivision of General Internal Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0003-2198-5278
Mohamed SaadClinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-2221-4216
Hamad Medical Corporation · QABirmingham Dental Hospital · GBCornell University · US

Funding

Medical Research Center, Hamad Medical Corporation MRC-01-21-746
6 · The paper itself

Abstract

WHAT IS KNOWN AND

objectiveThe scope of clinical pharmacy services has changed during COVID-19 pandemic with the view to mitigating both exposure and spread of the virus. The performance of novel pandemic-driven services such as tele-pharmacy has remained unexplored, until now. The aim of this study is to investigate the perceptions of healthcare providers of the impact of tele-pharmacy services provided in critical care units during COVID-19.

methodsA qualitative study of semi-structured interviews conducted with healthcare practitioners who worked in COVID-19 intensive care units and remotely interacted with clinical pharmacists at the Weill Cornell-affiliated Hamad Medical Corporation, Doha, Qatar. Random sampling technique was employed to recruit participants, with the resultant interview guide piloted before commencement of data collection process. RESULTS AND DISCUSSION: From a total 129 and 200 physicians and nurses, respectively, 20 interviews were conducted with physicians (n = 15), and nurses (n = 5). From these interactions, a number of major themes emerged including: satisfactory understanding across clinical environment and personnel (physician and nurses) about remote clinical pharmacists' roles; additional robust feedback on the perception of the remote clinical pharmacy service; an understanding by 'frontline' health personnel on the discernible differences between remote and in-person coverage of clinical pharmacists; a reflection by both physicians and nurses on the novel challenges involved in the implementation of such pandemic-driven service; and solutions to overcome these challenges. WHAT IS NEW AND

conclusionIn this novel qualitative study of pandemic-driven tele-pharmacy service, we found a positive perception amongst healthcare practitioners towards this service; with residual challenges that will need further evaluation by large sampled sized surveys or mixed methods research.

Indexed as

Community Pharmacy ServicesCOVID-19Pharmacy Service, HospitalAttitude of Health PersonnelCritical CareHumansPandemicsPharmacistsProfessional Roleclinical pharmacyCOVID-19intensive care unitqualitativetele-pharmacy

Identifiers

PMID35699243
PMCPMC9350019
OpenAlexW4282917651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.